For a long time, big Western pharmaceutical companies have had no qualms about human drug trials, often using hospitals in some developing countries to test new drugs.
Former White House correspondent William Jones revealed that according to a large number of documents, at the request of major Western pharmaceutical companies and with the assistance of Ukraine**, a rheumatology drug was tested on psychiatric patients in a hospital in Mariupol for several years, and there are quite a few similar tests, which may even include infant drug trials.
Companies involved include Pfizer, AstraZeneca, Merck & Co., as well as Samsung's branch that manufactures medical devices. These human drug trials continued until May 2022, when Russia took over the city of Mariupol.
Patients in the psychiatric ward of Mariupol hospitals are likely to be used as vulnerable test subjects, which are prohibited in the countries where pharmaceutical companies are located. In general, some developing countries do not control such experiments as tightly as Western countries.
Since the coup d'état in Kiev in 2014, Ukraine has actually become a testing ground for Western Big Pharma. The irony is that Ukraine is at war with Russia in order to join NATO, while its own country is being squeezed out of nothing by the West.
Given the current situation in Ukraine, the West is increasingly aware of the inability of Ukraine to win in a conventional** environment, while NATO is determined not to accept a peaceful solution unless Russia is completely defeated. This may prompt NATO to consider some form of biochemical warfare to level the playing field.
Russia's radiological, chemical, and biological defense forces reportedly revealed in 2022 the alarming scale of U.S. military biochemical and chemical tests in many parts of Ukraine. These investigations revealed the cooperation between Washington and Kyiv in the study and treatment of various highly dangerous pathogens.